REPLY
Does Acyclovir Worsen Late Varicella?
Mark R. Wallace;
Stephanie K. Brodine; and
Edward C. Oldfield
1 March 1993 | Volume 118 Issue 5 | Pages 394-395
IN RESPONSE:
We appreciate Dr. Klein's comments on our recent article. We also were puzzled by the statistically significant differences in new lesion formation and maximum number of lesions favoring placebo in the late treatment group (24 to 72 hours after rash onset). We suspect that these differences are partially the result of the randomization of a relatively small group of patients (72) yielding a late placebo group with a lesion count at entry of 20% less than that of the acyclovir group. Not surprisingly, given their initially lower lesion counts, the placebo group had a lower maximum number of lesions. Despite the favoring of the placebo group by other parameters, the duration of fever was slightly less in the acyclovir-treated group. We can think of no reason why acyclovir would worsen the course of varicella in late-presenting patients. We agree with Dr. Klein's conclusion that delayed administration (> 24 hours after rash onset) of acyclovir in patients with uncomplicated varicella is unwarranted.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.